• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰抑制素及其33 - 49 C末端片段在体内可抑制胰高血糖素刺激的胰岛素分泌。

Pancreastatin and its 33-49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo.

作者信息

Sánchez-Margalet V, Calvo J R, Lucas M, Goberna R

机构信息

Department of Medical Biochemistry and Molecular Biology, Medical School, University of Sevilla, Spain.

出版信息

Gen Pharmacol. 1992 Jul;23(4):637-8. doi: 10.1016/0306-3623(92)90140-f.

DOI:10.1016/0306-3623(92)90140-f
PMID:1397969
Abstract
  1. Pancreastatin, a 49 amino acid peptide derived from chromogranin A, has been shown to have an inhibitory effect on insulin secretion in the perfused pancreas and isolated islets. 2. We have studied the effect of pancreastatin on glucagon-stimulated insulin release and the hyperglycemic of glucagon effect in vivo. 3. When administered in the mesenteric vein, pancreastatin inhibited the increase in insulin levels induced by glucagon stimulation, thereby potentiating the hyperglycemic effect of glucagon. 4. This study describes a regulatory role of pancreastatin on glucagon-induced insulin release in vivo.
摘要
  1. 胰抑制素是一种由嗜铬粒蛋白A衍生而来的49个氨基酸的肽,已被证明对灌注胰腺和分离胰岛中的胰岛素分泌具有抑制作用。2. 我们研究了胰抑制素对胰高血糖素刺激的胰岛素释放的影响以及胰高血糖素在体内的高血糖作用。3. 当通过肠系膜静脉给药时,胰抑制素抑制了胰高血糖素刺激引起的胰岛素水平升高,从而增强了胰高血糖素的高血糖作用。4. 本研究描述了胰抑制素在体内对胰高血糖素诱导的胰岛素释放的调节作用。

相似文献

1
Pancreastatin and its 33-49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo.胰抑制素及其33 - 49 C末端片段在体内可抑制胰高血糖素刺激的胰岛素分泌。
Gen Pharmacol. 1992 Jul;23(4):637-8. doi: 10.1016/0306-3623(92)90140-f.
2
Pancreastatin inhibits insulin secretion as induced by glucagon, vasoactive intestinal peptide, gastric inhibitory peptide, and 8-cholecystokinin in the perfused rat pancreas.胰抑制素可抑制胰高血糖素、血管活性肠肽、胃抑制肽和八肽胆囊收缩素在灌注大鼠胰腺中诱导的胰岛素分泌。
Metabolism. 1989 Jul;38(7):679-82. doi: 10.1016/0026-0495(89)90107-8.
3
Glucogenolytic and hyperglycemic effect of 33-49 C-terminal fragment of pancreastatin in the rat in vivo.胰抑制素33 - 49 C末端片段在大鼠体内的糖原分解和升血糖作用。
Horm Metab Res. 1992 Oct;24(10):455-7. doi: 10.1055/s-2007-1003361.
4
Bioactivity of synthetic C-terminal fragment of rat pancreastatin on endocrine pancreas.大鼠胰抑制素合成C末端片段对内分泌胰腺的生物活性
Biochem Biophys Res Commun. 1989 Feb 15;158(3):844-9. doi: 10.1016/0006-291x(89)92799-x.
5
[Effect of pancreastatin on insulin secretion and the exocrine pancreas in rats].[胰抑制素对大鼠胰岛素分泌及外分泌胰腺的影响]
Z Gastroenterol. 1991 Oct;29(10):523-6.
6
Effects of pancreastatin on insulin, glucagon and somatostatin secretion by the perfused rat pancreas.胰抑制素对灌注大鼠胰腺胰岛素、胰高血糖素和生长抑素分泌的影响。
Life Sci. 1988;42(14):1361-7. doi: 10.1016/0024-3205(88)90165-8.
7
Pancreastatin (33-49) enhances the priming effect of glucose in the rat pancreas.胰抑制素(33 - 49)增强了葡萄糖对大鼠胰腺的启动作用。
Experientia. 1993 Jul 5;49(6-7):551-2. doi: 10.1007/BF01955161.
8
Effects of pancreastatin and chromogranin A on insulin release stimulated by various insulinotropic agents.胰抑制素和嗜铬粒蛋白A对多种促胰岛素分泌剂刺激的胰岛素释放的影响。
Regul Pept. 1991 Jun 11;34(1):25-32. doi: 10.1016/0167-0115(91)90221-2.
9
Bioactivity of human pancreastatin and its localization in pancreas.人胰抑制素的生物活性及其在胰腺中的定位。
Biochem Biophys Res Commun. 1989 Mar 31;159(3):913-8. doi: 10.1016/0006-291x(89)92195-5.
10
Rat pancreastatin inhibits both pancreatic exocrine and endocrine secretions in rats.大鼠胰抑制素可抑制大鼠胰腺的外分泌和内分泌分泌。
Regul Pept. 1990 Apr 24;28(2):189-98. doi: 10.1016/0167-0115(90)90017-q.

引用本文的文献

1
The extended granin family: structure, function, and biomedical implications.延伸的颗粒家族:结构、功能和生物医学意义。
Endocr Rev. 2011 Dec;32(6):755-97. doi: 10.1210/er.2010-0027. Epub 2011 Aug 23.
2
Global metabolic consequences of the chromogranin A-null model of hypertension: transcriptomic detection, pathway identification, and experimental verification.高血压的嗜铬粒蛋白 A 缺失模型的全球代谢后果:转录组检测、途径鉴定和实验验证。
Physiol Genomics. 2010 Feb 4;40(3):195-207. doi: 10.1152/physiolgenomics.00164.2009. Epub 2009 Dec 1.
3
A novel pathway of insulin sensitivity in chromogranin A null mice: a crucial role for pancreastatin in glucose homeostasis.
嗜铬粒蛋白A基因敲除小鼠中胰岛素敏感性的新途径:胰腺抑制素在葡萄糖稳态中的关键作用。
J Biol Chem. 2009 Oct 16;284(42):28498-509. doi: 10.1074/jbc.M109.020636. Epub 2009 Aug 25.
4
Catecholamine storage vesicles and the metabolic syndrome: The role of the chromogranin A fragment pancreastatin.儿茶酚胺储存囊泡与代谢综合征:嗜铬粒蛋白A片段胰抑制素的作用。
Diabetes Obes Metab. 2006 Nov;8(6):621-33. doi: 10.1111/j.1463-1326.2006.00575.x.
5
Pancreastatin (33-49) enhances the priming effect of glucose in the rat pancreas.胰抑制素(33 - 49)增强了葡萄糖对大鼠胰腺的启动作用。
Experientia. 1993 Jul 5;49(6-7):551-2. doi: 10.1007/BF01955161.
6
Pancreastatin activates protein kinase C by stimulating the formation of 1,2-diacylglycerol in rat hepatocytes.胰抑制素通过刺激大鼠肝细胞中1,2 - 二酰甘油的形成来激活蛋白激酶C。
Biochem J. 1994 Oct 1;303 ( Pt 1)(Pt 1):51-4. doi: 10.1042/bj3030051.